Biondo Investment Advisors LLC Decreases Stock Holdings in Intuitive Surgical, Inc. $ISRG

Biondo Investment Advisors LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 119,391 shares of the medical equipment provider’s stock after selling 2,790 shares during the quarter. Intuitive Surgical comprises about 8.2% of Biondo Investment Advisors LLC’s holdings, making the stock its largest position. Biondo Investment Advisors LLC’s holdings in Intuitive Surgical were worth $67,618,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Newbridge Financial Services Group Inc. grew its stake in shares of Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the last quarter. Holos Integrated Wealth LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $25,000. Olistico Wealth LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $28,000. Laurel Wealth Advisors LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $31,000. Finally, Turning Point Benefit Group Inc. grew its stake in shares of Intuitive Surgical by 833.3% during the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Iman Jeddi sold 5,625 shares of the stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the sale, the senior vice president directly owned 6,463 shares in the company, valued at approximately $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the completion of the sale, the director owned 120 shares in the company, valued at approximately $55,620. This trade represents a 49.79% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 7,169 shares of company stock worth $3,059,135. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $411.06 on Friday. The firm’s fifty day moving average is $442.88 and its two-hundred day moving average is $496.19. The firm has a market cap of $145.58 billion, a PE ratio of 49.83, a price-to-earnings-growth ratio of 3.28 and a beta of 1.46. Intuitive Surgical, Inc. has a twelve month low of $396.68 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.42. The company had revenue of $2.77 billion for the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business’s revenue for the quarter was up 23.0% compared to the same quarter last year. During the same period last year, the business posted $1.81 earnings per share. Equities analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analyst coverage remains broadly constructive, with brokerage sentiment still at a “Moderate Buy” and recent EPS estimate increases signaling confidence in Intuitive Surgical’s growth outlook.
• Positive Sentiment: Recent commentary highlights that the company’s scale, cost discipline, and adoption of the da Vinci 5 platform could help protect margins even if tariffs and input costs remain a concern.
• Neutral Sentiment: Investor attention has increased around ISRG, which can support trading activity, but this appears more like watchlist interest than a fresh business catalyst.
• Neutral Sentiment: BofA trimmed its price target slightly to $515 from $520, which still implies upside but signals a bit less optimism than before. Article: BofA adjusts price target on Intuitive Surgical to $515 from $520
• Neutral Sentiment: Two executives sold shares under pre-arranged 10b5-1 plans, including EVP Gary Loeb and EVP Mark Brosius. The sales were relatively small and routine, so they are unlikely to be a major fundamental concern.
• Negative Sentiment: One recent research note was notably bearish, with Deutsche Bank cutting its target to $366 and maintaining a sell rating, reinforcing concerns that valuation may still be too rich despite the company’s strong operating performance.
• Negative Sentiment: Seeking Alpha published a view calling Intuitive Surgical an “excellent business, unattractive stock,” reflecting ongoing investor caution around the valuation. Article: Intuitive Surgical: Excellent Business, Unattractive Stock

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. Evercore decreased their price target on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a research note on Monday, April 6th. Bank of America decreased their price target on shares of Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a research note on Monday, May 18th. Piper Sandler reissued an “overweight” rating and set a $580.00 price target on shares of Intuitive Surgical in a research note on Tuesday, June 2nd. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday, May 19th. Nineteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $571.28.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.